Takeda Pharmaceutical Company Limited | WebDisclosure

Basculer en Français

9473	Companies
185387	Keywords
117733	Articles
99269	Press releases

Headlines Articles Press releases Takeda Pharmaceutical Company Limited

Home
Companies
Takeda Pharmaceutical Company Limited

BRIEF

published on 10/30/2025 at 07:48, 1 month 6 days ago

Takeda Revises Financial Forecast for FY2025

Revenue Decline Financial Forecast Takeda FY2025 Profit Reduction
BRIEF

published on 10/30/2025 at 07:48, 1 month 6 days ago

Takeda revoit ses prévisions financières pour l'exercice 2025

Takeda Prévisions Financières Baisse Des Revenus Exercice 2025 Réduction Des Profits
PRESS RELEASE

published on 10/30/2025 at 07:43, 1 month 6 days ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
Takeda Pharmaceutical Company Limited revises FY2025 financial forecast due to strategic pipeline decisions and FX impact

Financial Forecast Revised Forecast Impairment Charges Takeda Pharmaceutical FY2025
BRIEF

published on 01/30/2025 at 09:36, 10 months 5 days ago

Julie Kim to Take Over as CEO of Takeda in 2026

Takeda CEO Transition Julie Kim Christophe Weber Retirement Pharmaceutical Leadership Corporate Succession
BRIEF

published on 01/30/2025 at 09:36, 10 months 5 days ago

Julie Kim prendra la direction générale de Takeda en 2026

Succession D'entreprise Julie Kim Transition Au Poste De PDG De Takeda Départ À La Retraite De Christophe Weber Leadership Pharmaceutique
PRESS RELEASE

published on 01/30/2025 at 09:31, 10 months 5 days ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Julie Kim to succeed Christophe Weber as CEO of Takeda in June 2026. Board unanimously appoints her to lead after Weber's 12 successful years. Succession process concluded

Takeda Leadership CEO Succession Julie Kim Christophe Weber
BRIEF

published on 01/30/2025 at 07:35, 10 months 6 days ago

Takeda Pharmaceutical Revises FY2024 Financial Forecast

Revenue Growth Financial Performance Operating Profit FY2024 Forecast Takeda Pharmaceutical
BRIEF

published on 01/30/2025 at 07:35, 10 months 6 days ago

Takeda Pharmaceutical révise ses prévisions financières pour l'exercice 2024

Performance Financière Croissance Des Revenus Bénéfice D'exploitation Prévisions Pour L'exercice 2024 Takeda Pharmaceutique
PRESS RELEASE

published on 01/30/2025 at 07:30, 10 months 6 days ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)
Takeda Pharmaceutical Company Limited announces revised financial forecast for FY2024, showing positive growth across revenue, profit, and earnings per share

Financial Forecast Takeda FY2024 Revised Forecast Core Financial Measures
BRIEF

published on 10/31/2024 at 07:05, 1 year 1 month ago

Takeda Revises FY2024 Financial Forecasts

Net Profit Growth Operating Profit Increase Takeda Financial Forecast FY2024 Revisions VYVANSE Impact

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 38 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 43 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 13 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 8 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 13 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:05, 8 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 12 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 12 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 13 minutes ago

Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 08:00, 13 minutes ago

Le Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) croît et est sur le point de franchir la barre des 500 millions

Les Echos

Published on 12/04/2025 at 18:14, 13 hours 58 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 13 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 13 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 28 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 28 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE